Comparing typical and atypical lupus symptoms
Part of Immune system & allergy, Skin clinical trials.
This study looks at how people with lupus (an autoimmune disease) do when they first have common symptoms versus unusual ones. It may help doctors understand which early signs matter most.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with lupus by a doctor
- Your first symptoms started between ages 20 and 50
- Your first symptoms can be classified as either typical (like rash, joint pain, or hair loss) or atypical (like seizures, heart or lung issues, or severe blood problems)
- You can give informed consent to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects health data from people recently diagnosed with lupus to improve treatment and care. It is a registry study, not a drug-testing trial, and aims to understand how patients fare over time.
This trial tests a new treatment for people with active lupus who haven't responded well to steroids and at least two other immune-suppressing drugs, including a biologic. It aims to find a better option for controlling lupus symptoms.
This research study aims to better understand systemic lupus erythematosus (SLE), an autoimmune disease where the body's immune system attacks its own tissues. Researchers will evaluate patients with lupus, study genetic factors, and perform optional imaging tests to learn how the disease affects blood vessels and the heart.
This study asks people with lupus to share their opinions through surveys to help researchers agree on better ways to measure the disease. Your input can help improve future lupus treatments.
This study looks at blood and immune cell markers (autoantibodies and immune cell “signatures”) to better understand autoimmune conditions, including lupus. It may help researchers identify which markers are linked to disease and how immune cells respond after vaccination.
This study is trying to better understand lupus (SLE) by looking at different types of the disease. It may help doctors find more personalized treatments in the future.
Hear when a new Systemic Lupus Erythematosus (SLE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.